Axa S.A. Infla Rx N.V. Transaction History

Axa S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$3.06 - $51.61 $305,663 - $5.16 Million	-99,890 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$31.16 - $48.62 $927,321 - $1.45 Million	-29,760 Reduced 22.95%	99,890 $3.78 Million
Q2 2018 Aug 13, 2018	BUY	$27.33 - $41.46 $588,961 - $893,463	21,550 Added 19.94%	129,650 $4.18 Million
Q1 2018 May 14, 2018	BUY	$20.21 - $32.0 $2.18 Million - $3.46 Million	108,100 New	108,100 $3.12 Million

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $98.6M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.